DT Investment Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-170
Closed -$25.3K – 623
2024
Q3
$25.3K Buy
170
+30
+21% +$4.3K ﹤0.01% 322
2024
Q2
$17.6K Buy
+140
New +$21.9K ﹤0.01% 328

Other funds holding RGEN

DT Investment Partners's RGEN Position: Q4 2024 in Review

DT Investment Partners sold out of Repligen (RGEN) in Q4 2024, closing a stake of 170 shares — an estimated $25.3K sold.

DT Investment Partners first reported a position in RGEN in Q2 2024 and held it in 2 quarters. The position peaked at $25.3K in Q3 2024. 431 funds tracked by Wall St. Rank hold RGEN as of Q4 2024.

  • DT Investment Partners reported no remaining Repligen position as of Q4 2024 after selling out during the quarter.
  • DT Investment Partners sold 170 Repligen shares in Q4 2024, an estimated $25.3K.
  • DT Investment Partners first reported a position in Repligen in Q2 2024 and held it in 2 quarters.
  • DT Investment Partners's Repligen position peaked at $25.3K in Q3 2024.
  • 431 funds tracked by Wall St. Rank held Repligen as of Q4 2024.

Based on DT Investment Partners's 13F filing for Q4 2024, filed 30 Jan 2025.